Acurx pharmaceuticals to present at the microcap conference, january 31, 2024 - february 1, 2024

Staten island, n.y. , jan. 23, 2024 /prnewswire/ -- acurx pharmaceuticals, inc. ("acurx" or the "company") (nasdaq: "acxp"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, today announced that david p.
ACXP Ratings Summary
ACXP Quant Ranking